Dune Medical Plans Summer Submission For Breast Cancer Probe PMA
This article was originally published in The Gray Sheet
Executive SummaryDune Medical will submit a PMA application this summer for its MarginProbe intraoperative real-time margin detection system for breast cancer surgery, according to Bill Densel, the firm's U.S. president
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.